Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,028 | 47 | 96.6% |
| Education | $35.95 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $240.88 | 18 | $0 (2019) |
| Allergan, Inc. | $166.66 | 11 | $0 (2020) |
| Alcon Laboratories Inc | $118.03 | 2 | $0 (2017) |
| Kala Pharmaceuticals, Inc. | $107.89 | 1 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $102.14 | 1 | $0 (2022) |
| CooperVision Inc. | $93.24 | 2 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $71.53 | 3 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $55.71 | 3 | $0 (2021) |
| Alcon Vision LLC | $28.67 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $27.43 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $102.14 | 1 | Bausch & Lomb Americas Inc. ($102.14) |
| 2021 | $27.83 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($14.66) |
| 2020 | $224.56 | 14 | Allergan, Inc. ($136.20) |
| 2019 | $180.38 | 5 | Kala Pharmaceuticals, Inc. ($107.89) |
| 2018 | $138.12 | 9 | Shire North American Group Inc ($107.87) |
| 2017 | $390.87 | 17 | Alcon Laboratories Inc ($118.03) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/03/2022 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $102.14 | General |
| Category: Ophthalmology | ||||||
| 03/03/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Ophthalmology | ||||||
| 02/10/2021 | CooperVision Inc. | Biofinity Contact Lens (Device) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Devices | ||||||
| 12/08/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/02/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2020 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Glaucoma | ||||||
| 09/11/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/03/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, BESIVANCE | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/18/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/20/2020 | Allergan, Inc. | LUMIGAN (Drug) | Education | In-kind items and services | $35.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/08/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/01/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/03/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/06/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/24/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: Ophthalmology | ||||||
| 01/15/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $23.56 | General |
| Category: Ophthalmology | ||||||
| 11/05/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $107.89 | General |
| Category: OCULAR | ||||||
| 08/28/2019 | Alcon Vision LLC | DAILIES (Device), AIR OPTIX | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Ophthalmology | ||||||
| 08/14/2019 | Alcon Vision LLC | Clear Care (Drug), DAILIES, AIR OPTIX | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Ophthalmology | ||||||
| 06/07/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: OPTHALMICS | ||||||
| 05/06/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/21/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: OPTHALMICS | ||||||
| 11/09/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: OPTHALMICS | ||||||
| 11/09/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 162 | 167 | $28,293 | $6,760 |
| 2021 | 3 | 59 | 60 | $8,802 | $3,630 |
| 2020 | 10 | 1,206 | 1,429 | $200,325 | $95,523 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 34 | 34 | $5,610 | $1,545 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 41 | 45 | $4,995 | $1,528 | 30.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,664 | $1,013 | 27.7% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 18 | 18 | $3,690 | $871.44 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $2,142 | $749.97 | 35.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 11 | 11 | $3,465 | $690.32 | 19.9% |
| 92250 | Photography of the retina | Facility | 2022 | 29 | 29 | $4,727 | $362.21 | 7.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 26 | 27 | $2,997 | $1,287 | 42.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 16 | 16 | $3,000 | $1,287 | 42.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 17 | 17 | $2,805 | $1,056 | 37.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 395 | 442 | $84,652 | $40,001 | 47.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 241 | 367 | $53,447 | $24,749 | 46.3% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 105 | 105 | $22,521 | $11,354 | 50.4% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 150 | 183 | $17,114 | $9,309 | 54.4% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 170 | 175 | $11,156 | $4,833 | 43.3% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 71 | 81 | $5,719 | $2,611 | 45.7% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2020 | 20 | 20 | $2,378 | $1,126 | 47.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 22 | 23 | $1,380 | $773.08 | 56.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 12 | $1,188 | $593.25 | 49.9% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2020 | 20 | 21 | $770.00 | $173.75 | 22.6% |
About Dr. Mary Sezer, O.D
Dr. Mary Sezer, O.D is a Optometrist healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386787299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Sezer, O.D has received a total of $1,064 in payments from pharmaceutical and medical device companies, with $102.14 received in 2022. These payments were reported across 48 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,028).
As a Medicare-enrolled provider, Sezer has provided services to 1,427 Medicare beneficiaries, totaling 1,656 services with total Medicare billing of $105,913. Data is available for 3 years (2020–2022), covering 20 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Augusta, GA
- Active Since 02/14/2007
- Last Updated 04/28/2022
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386787299
Products in Payments
- XIIDRA (Drug) $254.35
- LUMIGAN (Drug) $136.20
- INVELTYS (Drug) $107.89
- INFUSE (Device) $102.14
- Clariti Contact Lens (Device) $80.07
- CEQUA (Drug) $41.28
- PROLENSA (Drug) $40.82
- RESTASIS (Drug) $30.46
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $30.25
- TearLab Osmolarity System (Device) $18.34
- rhopressa (Drug) $17.59
- VYZULTA (Drug) $16.02
- Clear Care (Drug) $15.71
- ULTRA (Device) $14.66
- TRAVATAN Z (Drug) $13.96
- Biofinity Contact Lens (Device) $13.17
- DAILIES (Device) $12.96
- Clear Care (Device) $2.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Augusta
Jessilin Quint, O.d, O.D
Optometrist — Payments: $222,251
Anthony Hartness, O. D, O. D
Optometrist — Payments: $9,392
Dr. Robert Morgan, O.d, O.D
Optometrist — Payments: $5,405
Douglas Ellenberger, Od, OD
Optometrist — Payments: $4,579
Alexandra Grotton
Optometrist — Payments: $3,673
Dr. Keisha Williford, Od, OD
Optometrist — Payments: $3,600